Email
IZ Express #1,681: Immunize.org’s “Improving the Vaccination Experience” webinar available on-demand, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,681: Immunize.org’s “Improving the Vaccination Experience” webinar available on-demand, and more |
| Date | March 8, 2023 11:00 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,681: March 8, 2023
Top Stories
* Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available for on-demand viewing
* CDC's Health Alert Network issues advisory concerning measles exposure at a large, multistate gathering in Kentucky, February 2023
* Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
* Influenza activity is low, but still circulating; keep encouraging vaccination
* Spotlight: Immunize.org resources focused on vaccination during pregnancy
* Journalists interview Immunize.org experts
* Vaccines in the news
Vaccine Information Statements
* Immunize.org posts 15 new Vaccine Information Statements in Pashto (#IZX8)
* Immunize.org posts 17 new and updated Vaccine Information Statements in Dari
Featured Resources
* NFID posts new podcast episode featuring Walter A. Orenstein, MD, discussing baseball and his role in shaping vaccine policy
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Notable Publications
* Pediatric Clinics of North America publishes issue with 15 articles on addressing hesitancy
* “Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence” published in Pediatrics
Global News
* WHO and public health partners revitalize measles and rubella reduction initiative
Upcoming Events
* Virtual: Mark your calendar! NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration opens later in March.
* Virtual: American College Health Association offers third in five-part webinar series Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available for on-demand viewing
On February 28, Immunize.org and Canadian experts from the Hospital for Sick Children (SickKids), Toronto, and Society for Infodemic Management, Québec, hosted a 1-hour webinar, Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) . During this webinar, participants learned more about the principles behind vaccination pain and anxiety and simple, evidence-based strategies to reduce apprehension. These strategies were developed by the experts from HELP Eliminate Pain in Kids and Adults ([link removed]) . Their work was used by the World Health Organization (WHO), Public Health Canada, and others to develop guidelines for reducing vaccination pain.
The video of the webinar, slide set, and web links to other resources are now available on our website for on-demand viewing ([link removed]) . Please view and share this important webinar with your colleagues.
[link removed]
Related Link
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) (webinar held on 12/13/22)
------------------------------------------------------------
CDC's Health Alert Network issues advisory concerning measles exposure at a large, multistate gathering in Kentucky, February 2023
On March 3, CDC issued a Health Alert Network (HAN) Health Advisory: Measles Exposure at a Large Gathering in Kentucky, February 2023 and Global Measles Outbreaks ([link removed]) . The summary section appears below.
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and public health officials about a confirmed measles case at a large gathering. On February 24, 2023, the Kentucky Department for Public Health (KDPH) identified a confirmed case of measles in an unvaccinated individual with a history of recent international travel. While infectious, the individual attended a large religious gathering on February 17–18, 2023, at Asbury University in Wilmore, Kentucky. An estimated 20,000 people attended the gathering from Kentucky, other U.S. states, and other countries during February 17–18, and an undetermined number of these people may have been exposed. This Health Advisory also highlights other recent large global measles outbreaks and associated U.S. importations, and the importance of early recognition, diagnosis, and appropriate treatment. CDC recommends that clinicians be on alert for cases of measles that meet
the case definition. ([link removed])
[link removed]
Access the complete CDC HAN Health Advisory message. ([link removed])
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Influenza activity is low, but still circulating; keep encouraging vaccination
CDC continues to recommend influenza vaccination for those not yet protected as long as influenza is circulating. Keep in mind young children who still need a second dose in their first vaccination season and those who need vaccination during pregnancy.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , provides a valuable snapshot of influenza activity state by state. For week 8, ending February 25, FluView ([link removed]) reports that 2.6% of outpatient visits nationwide were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). The national baseline is 2.5%. Multiple respiratory viruses are co-circulating; the relative contribution of influenza virus infection to ILI varies by location. So far this season, 117 children died from influenza-associated causes.
[link removed]
Influenza Vaccination Dashboard
CDC’s Weekly Flu Vaccination Dashboard ([link removed]) shows that coverage for all pregnant persons age 18–49 as of the end of January 2023 is 47.9%, lowest (29.7%) for Black, Non-Hispanic (NH) pregnant persons, and highest (65.9%) for Asian, NH pregnant persons.
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that influenza vaccine has provided substantial protection to children and adults this season against illness and hospitalization.
CDC recommends everyone age 6 months and older get annual influenza vaccination. “Vaccines.gov” offers VaccineFinder ([link removed]) , a service of Boston Children’s Hospital, to help people find influenza and COVID-19 vaccines for any age group. To be listed as a provider by VaccineFinder, see the information at this website ([link removed]) .
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Respiratory Virus Hospitalization Surveillance Network ([link removed]) (Resp-NET) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Spotlight: Immunize.org resources focused on vaccination during pregnancy
In this week's Spotlight, we summarize resources at Immunize.org that focus on vaccination during pregnancy.
Handouts: Pregnancy and Vaccines ([link removed]) main page offers free access to pregnancy and vaccination-related handouts and fact sheets for healthcare professionals and the public. All items are ready to print, copy, and distribute widely.
Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page links you to forms that patients fill out to expedite assessment of vaccination needs and contraindications. These include the labor and delivery HBsAg admission checklist.
Adult Vaccination ([link removed]) main page contains all the Immunize.org handouts that pertain to adult vaccination. These include the Summary of Recommendations for Adult Immunization ([link removed]) that highlights the CDC recommendations for vaccination during pregnancy.
CDC Schedules ([link removed]) main page provides printable PDF versions of the recommended immunization schedules for adults. The first column in Table 2 of the adult schedule lists the vaccines to give or defer during pregnancy.
------------------------------------------------------------
Journalists interview Immunize.org experts
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is one of our recent citations.
* Washington Post: Novavax Was a COVID Vaccine Underdog. Now It’s in Financial Trouble. ([link removed]) (3/1/2023)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CBS: Flu and COVID Combo Shots Won’t Come in Time for This Year, FDA Official Says ([link removed]) (3/2/23)
* WHO: Recommendations Announced for Influenza Vaccine Composition for the 2023–2024 Northern Hemisphere Influenza Season ([link removed]) (2/24/23)
* Reuters: Pfizer/BioNTech Apply for Full FDA Approval of Updated COVID Vaccine ([link removed]) (2/24/23)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Immunize.org posts 15 new Vaccine Information Statements in Pashto
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. Fifteen new VIS translations in Pashto were generously donated by the Minnesota Department of Health.
All translations are available in print-ready PDF format.
New VIS translations in Pashto ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Hepatitis B ([link removed]) VIS
* Haemophilus influenzae type b (Hib) ([link removed]) VIS
* HPV (Human Papillomavirus) ([link removed]) VIS
* Influenza (Live Intranasal) ([link removed]) VIS
* Meningococcal ACWY ([link removed]) VIS
* Meningococcal B ([link removed]) VIS
* MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Multi-vaccine ([link removed]) VIS
* Pneumococcal Conjugate (PCV) ([link removed]) VIS
* Pneumococcal Polysaccharide (PPSV23) ([link removed]) VIS
* Rotavirus ([link removed]) VIS
* Td (Tetanus, Diphtheria) ([link removed]) VIS
* Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Pashto-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 17 new and updated Vaccine Information Statements in Dari
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. Seventeen new and updated VIS translations in Dari were generously donated by the Minnesota Department of Health.
All translations are available in print-ready PDF format.
VIS translations in Dari ([link removed]) :
Updated:
* Hepatitis A ([link removed]) VIS
* Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Influenza (Inactivated or Recombinant) ([link removed]) VIS
New:
* DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Hepatitis B ([link removed]) VIS
* HPV (Human Papillomavirus) ([link removed]) VIS
* Influenza (Live Intranasal) ([link removed]) VIS
* Meningococcal ACWY ([link removed]) VIS
* Meningococcal B ([link removed]) VIS
* MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Multi-vaccine ([link removed]) VIS
* Pneumococcal Conjugate (PCV) ([link removed]) VIS
* Pneumococcal Polysaccharide (PPSV23) ([link removed]) VIS
* Rotavirus ([link removed]) VIS
* Td (Tetanus, Diphtheria) ([link removed]) VIS
* Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Dari-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
NFID posts new podcast episode featuring Walter A. Orenstein, MD, discussing baseball and his role in shaping vaccine policy
Infectious IDeas ([link removed]) , a podcast series presented by the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations that lead to infectious ideas. The latest entry in the series, From Baseball to Epidemiology ([link removed]) , features Walter A. Orenstein, MD, Emory University. A description from the web page appears below.
An avid baseball fan who has played a pivotal role in shaping vaccine policy in the US and globally, Walter A. Orenstein, MD, reflects on lessons learned from smallpox, measles, polio, and how his love of baseball influenced a remarkable career in epidemiology and public health.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
Pediatric Clinics of North America publishes issue with 15 articles on addressing hesitancy
The April 2023 issue of Pediatric Clinics of North America ([link removed]) features 15 articles on vaccine hesitancy. Some articles are free of charge and some require a subscription. The collection was edited by Peter Szilagyi, Tamera Coyne-Beasley, and Immunize.org's Sharon Humiston. These three pediatricians also wrote the preface titled Addressing Vaccine Hesitancy for Child and Adolescent Vaccines: The Next Big Challenge ([link removed]) . Portions of the preface appear below.
This issue of Pediatric Clinics of North America takes a deep look at vaccine hesitancy, how it affects vaccine uptake, and what we know about strategies to address it. The articles provide an overview of vaccine hesitancy from both a public health and a clinical perspective. You will see in this issue that authors define vaccine hesitancy in different ways. However, each group of authors highlights how the factors that lead to vaccine reluctance or refusal differ depending on the vaccine (please see the articles in this issue on influenza, HPV, and COVID-19 vaccination) as well as factors associated with the vaccination target population and decision makers. . . .
This entire journal issue, and one article in particular [A Structural Lens Approach to Vaccine Hesitancy and Identity ([link removed]) ], emphasizes that vaccine hesitancy needs to be understood in the context of historical and contemporary racism, as well as other lived experiences, including medical exploitation, that have engendered mistrust.
[link removed]
------------------------------------------------------------
“Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence” published in Pediatrics
In the March 2023 issue, Pediatrics published Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence ([link removed]) . A portion of the conclusions section appears below.
In conclusion, this study provides evidence that moving routine HPV vaccination from ages 11 to 12 years to ages 9 to 10 years may improve vaccination coverage rates in early and mid-adolescence, thereby increasing the public health benefit of vaccination. Providers should be vigilant to patient interactions after initiation of HPV vaccination to ensure series completion within the recommended time frame. Future research on acceptability of and barriers to routine vaccination at ages 9 to 10 years could promote uptake and completion before sexual debut, thereby maximizing HPV vaccine effectiveness.
------------------------------------------------------------
Global News
------------------------------------------------------------
WHO and public health partners revitalize measles and rubella reduction initiative
On February 22, the World Health Organization (WHO) and partners issued a joint statement, A New Era in the Fight against Measles and Rubella ([link removed]) , on the revitalized Measles and Rubella Initiative (M&RI) partnership, now called the IA2030 Measles & Rubella Partnership ([link removed]) (M&RP).
The Measles and Rubella Initiative (M&RI), a product of WHO and partners, saved over 56 million lives globally since its formation. The collaboration among countries and other partners aims to achieve the Immunization Agenda 2030 (IA2030) target to save another 50 million lives through access to essential vaccines. Measles vaccination is a critical step in that life-saving goal.
WHO and its founding partners adopted the Measles and Rubella Strategic Framework 2030 ([link removed]) , an ambitious global strategy to maximize the lifesaving impact of vaccines. As a result, the revitalized alliance will now be called the IA2030 Measles & Rubella Partnership ([link removed]) (M&RP).
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: Mark your calendar! NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration opens later in March.
The National Foundation for Infectious Diseases (NFID) will host its 2023 Annual Conference on Vaccinology Research ([link removed]) (ACVR) on June 5–7. Learn and network with hundreds of researchers and healthcare professionals from around the world. The conference will feature informative presentations with interactive audience discussions, peer-reviewed oral and poster abstracts, and an inspiring session spotlighting women leaders in vaccinology.
Registration will open later in March 2023. Visit the ACVR website ([link removed]) for updates and additional information.
[link removed]
The deadline to submit an abstract ([link removed]) is March 28, 2023.
There is a $300 fee to attend. NFID will offer CME for the live activity.
Registration will be made available on the 2023 Annual Conference on Vaccinology Research ([link removed]) website in March.
------------------------------------------------------------
Virtual: American College Health Association offers third in five-part webinar series Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
The American College Health Association (ACHA) is offering a free, five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students ([link removed]) . This five-part webinar series will provide tools for campus personnel in all disciplines to use when working with students to help them navigate misinformation, disinformation, and the infodemic. Webinars include:
* January 10 – "Health Literacy 101" (available on-demand ([link removed]) )
* February 21 – "Digital Wellbeing and Mental Health: Helping Me Is Helping We" (available on-demand ([link removed]) )
* March 7 – "Debunking Fake News" (available on-demand ([link removed]) )
* April 18 – "Confronting Misinformation in Our Circles of Influence"
* May 9 – "Managing the Infodemic: Getting Started"
Each session airs 12:00–1:00 p.m. (ET). Up to 5 hours of credit are available for CNE, CME, and CHES, and 1.0 CE is available for counselors specifically for session 2.
Register for the free webinars ([link removed]) .
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,681: March 8, 2023
Top Stories
* Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available for on-demand viewing
* CDC's Health Alert Network issues advisory concerning measles exposure at a large, multistate gathering in Kentucky, February 2023
* Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
* Influenza activity is low, but still circulating; keep encouraging vaccination
* Spotlight: Immunize.org resources focused on vaccination during pregnancy
* Journalists interview Immunize.org experts
* Vaccines in the news
Vaccine Information Statements
* Immunize.org posts 15 new Vaccine Information Statements in Pashto (#IZX8)
* Immunize.org posts 17 new and updated Vaccine Information Statements in Dari
Featured Resources
* NFID posts new podcast episode featuring Walter A. Orenstein, MD, discussing baseball and his role in shaping vaccine policy
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Notable Publications
* Pediatric Clinics of North America publishes issue with 15 articles on addressing hesitancy
* “Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence” published in Pediatrics
Global News
* WHO and public health partners revitalize measles and rubella reduction initiative
Upcoming Events
* Virtual: Mark your calendar! NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration opens later in March.
* Virtual: American College Health Association offers third in five-part webinar series Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org’s webinar, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults,” now available for on-demand viewing
On February 28, Immunize.org and Canadian experts from the Hospital for Sick Children (SickKids), Toronto, and Society for Infodemic Management, Québec, hosted a 1-hour webinar, Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults ([link removed]) . During this webinar, participants learned more about the principles behind vaccination pain and anxiety and simple, evidence-based strategies to reduce apprehension. These strategies were developed by the experts from HELP Eliminate Pain in Kids and Adults ([link removed]) . Their work was used by the World Health Organization (WHO), Public Health Canada, and others to develop guidelines for reducing vaccination pain.
The video of the webinar, slide set, and web links to other resources are now available on our website for on-demand viewing ([link removed]) . Please view and share this important webinar with your colleagues.
[link removed]
Related Link
* Immunize.org: Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age ([link removed]) (webinar held on 12/13/22)
------------------------------------------------------------
CDC's Health Alert Network issues advisory concerning measles exposure at a large, multistate gathering in Kentucky, February 2023
On March 3, CDC issued a Health Alert Network (HAN) Health Advisory: Measles Exposure at a Large Gathering in Kentucky, February 2023 and Global Measles Outbreaks ([link removed]) . The summary section appears below.
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and public health officials about a confirmed measles case at a large gathering. On February 24, 2023, the Kentucky Department for Public Health (KDPH) identified a confirmed case of measles in an unvaccinated individual with a history of recent international travel. While infectious, the individual attended a large religious gathering on February 17–18, 2023, at Asbury University in Wilmore, Kentucky. An estimated 20,000 people attended the gathering from Kentucky, other U.S. states, and other countries during February 17–18, and an undetermined number of these people may have been exposed. This Health Advisory also highlights other recent large global measles outbreaks and associated U.S. importations, and the importance of early recognition, diagnosis, and appropriate treatment. CDC recommends that clinicians be on alert for cases of measles that meet
the case definition. ([link removed])
[link removed]
Access the complete CDC HAN Health Advisory message. ([link removed])
------------------------------------------------------------
Order today! Laminated versions of CDC’s 2023 immunization schedules now available and shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Influenza activity is low, but still circulating; keep encouraging vaccination
CDC continues to recommend influenza vaccination for those not yet protected as long as influenza is circulating. Keep in mind young children who still need a second dose in their first vaccination season and those who need vaccination during pregnancy.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , provides a valuable snapshot of influenza activity state by state. For week 8, ending February 25, FluView ([link removed]) reports that 2.6% of outpatient visits nationwide were due to respiratory illness that included fever plus a cough or sore throat (i.e., influenza-like illness [ILI]). The national baseline is 2.5%. Multiple respiratory viruses are co-circulating; the relative contribution of influenza virus infection to ILI varies by location. So far this season, 117 children died from influenza-associated causes.
[link removed]
Influenza Vaccination Dashboard
CDC’s Weekly Flu Vaccination Dashboard ([link removed]) shows that coverage for all pregnant persons age 18–49 as of the end of January 2023 is 47.9%, lowest (29.7%) for Black, Non-Hispanic (NH) pregnant persons, and highest (65.9%) for Asian, NH pregnant persons.
CDC posted a spotlight on influenza vaccine effectiveness (VE) ([link removed]) this season. Multiple estimates show that influenza vaccine has provided substantial protection to children and adults this season against illness and hospitalization.
CDC recommends everyone age 6 months and older get annual influenza vaccination. “Vaccines.gov” offers VaccineFinder ([link removed]) , a service of Boston Children’s Hospital, to help people find influenza and COVID-19 vaccines for any age group. To be listed as a provider by VaccineFinder, see the information at this website ([link removed]) .
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: Respiratory Virus Hospitalization Surveillance Network ([link removed]) (Resp-NET) main page
* Immunize.org: free educational materials and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines: Influenza ([link removed]) main page
* Immunize.org: Ask the Experts: Influenza ([link removed]) main page
------------------------------------------------------------
Spotlight: Immunize.org resources focused on vaccination during pregnancy
In this week's Spotlight, we summarize resources at Immunize.org that focus on vaccination during pregnancy.
Handouts: Pregnancy and Vaccines ([link removed]) main page offers free access to pregnancy and vaccination-related handouts and fact sheets for healthcare professionals and the public. All items are ready to print, copy, and distribute widely.
Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page links you to forms that patients fill out to expedite assessment of vaccination needs and contraindications. These include the labor and delivery HBsAg admission checklist.
Adult Vaccination ([link removed]) main page contains all the Immunize.org handouts that pertain to adult vaccination. These include the Summary of Recommendations for Adult Immunization ([link removed]) that highlights the CDC recommendations for vaccination during pregnancy.
CDC Schedules ([link removed]) main page provides printable PDF versions of the recommended immunization schedules for adults. The first column in Table 2 of the adult schedule lists the vaccines to give or defer during pregnancy.
------------------------------------------------------------
Journalists interview Immunize.org experts
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is one of our recent citations.
* Washington Post: Novavax Was a COVID Vaccine Underdog. Now It’s in Financial Trouble. ([link removed]) (3/1/2023)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CBS: Flu and COVID Combo Shots Won’t Come in Time for This Year, FDA Official Says ([link removed]) (3/2/23)
* WHO: Recommendations Announced for Influenza Vaccine Composition for the 2023–2024 Northern Hemisphere Influenza Season ([link removed]) (2/24/23)
* Reuters: Pfizer/BioNTech Apply for Full FDA Approval of Updated COVID Vaccine ([link removed]) (2/24/23)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Immunize.org posts 15 new Vaccine Information Statements in Pashto
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. Fifteen new VIS translations in Pashto were generously donated by the Minnesota Department of Health.
All translations are available in print-ready PDF format.
New VIS translations in Pashto ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Hepatitis B ([link removed]) VIS
* Haemophilus influenzae type b (Hib) ([link removed]) VIS
* HPV (Human Papillomavirus) ([link removed]) VIS
* Influenza (Live Intranasal) ([link removed]) VIS
* Meningococcal ACWY ([link removed]) VIS
* Meningococcal B ([link removed]) VIS
* MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Multi-vaccine ([link removed]) VIS
* Pneumococcal Conjugate (PCV) ([link removed]) VIS
* Pneumococcal Polysaccharide (PPSV23) ([link removed]) VIS
* Rotavirus ([link removed]) VIS
* Td (Tetanus, Diphtheria) ([link removed]) VIS
* Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Pashto-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Immunize.org posts 17 new and updated Vaccine Information Statements in Dari
Immunize.org expanded its collection of Vaccination Information Statement (VIS) ([link removed]) translations. Seventeen new and updated VIS translations in Dari were generously donated by the Minnesota Department of Health.
All translations are available in print-ready PDF format.
VIS translations in Dari ([link removed]) :
Updated:
* Hepatitis A ([link removed]) VIS
* Haemophilus influenzae type b (Hib) ([link removed]) VIS
* Influenza (Inactivated or Recombinant) ([link removed]) VIS
New:
* DTaP (Diphtheria, Tetanus, Pertussis) ([link removed]) VIS
* Hepatitis B ([link removed]) VIS
* HPV (Human Papillomavirus) ([link removed]) VIS
* Influenza (Live Intranasal) ([link removed]) VIS
* Meningococcal ACWY ([link removed]) VIS
* Meningococcal B ([link removed]) VIS
* MMRV (Measles, Mumps, Rubella, and Varicella) ([link removed]) VIS
* Multi-vaccine ([link removed]) VIS
* Pneumococcal Conjugate (PCV) ([link removed]) VIS
* Pneumococcal Polysaccharide (PPSV23) ([link removed]) VIS
* Rotavirus ([link removed]) VIS
* Td (Tetanus, Diphtheria) ([link removed]) VIS
* Tdap (Tetanus, Diphtheria, Pertussis) ([link removed]) VIS
* Recombinant Zoster (Shingles) ([link removed]) VIS
Check the version dates of your office copies of newly updated translations. Translations of previous VIS versions should be discarded now that translations of the current versions are available.
Related Links
* Immunize.org: Dari-Language VISs ([link removed]) main page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
NFID posts new podcast episode featuring Walter A. Orenstein, MD, discussing baseball and his role in shaping vaccine policy
Infectious IDeas ([link removed]) , a podcast series presented by the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations that lead to infectious ideas. The latest entry in the series, From Baseball to Epidemiology ([link removed]) , features Walter A. Orenstein, MD, Emory University. A description from the web page appears below.
An avid baseball fan who has played a pivotal role in shaping vaccine policy in the US and globally, Walter A. Orenstein, MD, reflects on lessons learned from smallpox, measles, polio, and how his love of baseball influenced a remarkable career in epidemiology and public health.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
Pediatric Clinics of North America publishes issue with 15 articles on addressing hesitancy
The April 2023 issue of Pediatric Clinics of North America ([link removed]) features 15 articles on vaccine hesitancy. Some articles are free of charge and some require a subscription. The collection was edited by Peter Szilagyi, Tamera Coyne-Beasley, and Immunize.org's Sharon Humiston. These three pediatricians also wrote the preface titled Addressing Vaccine Hesitancy for Child and Adolescent Vaccines: The Next Big Challenge ([link removed]) . Portions of the preface appear below.
This issue of Pediatric Clinics of North America takes a deep look at vaccine hesitancy, how it affects vaccine uptake, and what we know about strategies to address it. The articles provide an overview of vaccine hesitancy from both a public health and a clinical perspective. You will see in this issue that authors define vaccine hesitancy in different ways. However, each group of authors highlights how the factors that lead to vaccine reluctance or refusal differ depending on the vaccine (please see the articles in this issue on influenza, HPV, and COVID-19 vaccination) as well as factors associated with the vaccination target population and decision makers. . . .
This entire journal issue, and one article in particular [A Structural Lens Approach to Vaccine Hesitancy and Identity ([link removed]) ], emphasizes that vaccine hesitancy needs to be understood in the context of historical and contemporary racism, as well as other lived experiences, including medical exploitation, that have engendered mistrust.
[link removed]
------------------------------------------------------------
“Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence” published in Pediatrics
In the March 2023 issue, Pediatrics published Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence ([link removed]) . A portion of the conclusions section appears below.
In conclusion, this study provides evidence that moving routine HPV vaccination from ages 11 to 12 years to ages 9 to 10 years may improve vaccination coverage rates in early and mid-adolescence, thereby increasing the public health benefit of vaccination. Providers should be vigilant to patient interactions after initiation of HPV vaccination to ensure series completion within the recommended time frame. Future research on acceptability of and barriers to routine vaccination at ages 9 to 10 years could promote uptake and completion before sexual debut, thereby maximizing HPV vaccine effectiveness.
------------------------------------------------------------
Global News
------------------------------------------------------------
WHO and public health partners revitalize measles and rubella reduction initiative
On February 22, the World Health Organization (WHO) and partners issued a joint statement, A New Era in the Fight against Measles and Rubella ([link removed]) , on the revitalized Measles and Rubella Initiative (M&RI) partnership, now called the IA2030 Measles & Rubella Partnership ([link removed]) (M&RP).
The Measles and Rubella Initiative (M&RI), a product of WHO and partners, saved over 56 million lives globally since its formation. The collaboration among countries and other partners aims to achieve the Immunization Agenda 2030 (IA2030) target to save another 50 million lives through access to essential vaccines. Measles vaccination is a critical step in that life-saving goal.
WHO and its founding partners adopted the Measles and Rubella Strategic Framework 2030 ([link removed]) , an ambitious global strategy to maximize the lifesaving impact of vaccines. As a result, the revitalized alliance will now be called the IA2030 Measles & Rubella Partnership ([link removed]) (M&RP).
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: Mark your calendar! NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration opens later in March.
The National Foundation for Infectious Diseases (NFID) will host its 2023 Annual Conference on Vaccinology Research ([link removed]) (ACVR) on June 5–7. Learn and network with hundreds of researchers and healthcare professionals from around the world. The conference will feature informative presentations with interactive audience discussions, peer-reviewed oral and poster abstracts, and an inspiring session spotlighting women leaders in vaccinology.
Registration will open later in March 2023. Visit the ACVR website ([link removed]) for updates and additional information.
[link removed]
The deadline to submit an abstract ([link removed]) is March 28, 2023.
There is a $300 fee to attend. NFID will offer CME for the live activity.
Registration will be made available on the 2023 Annual Conference on Vaccinology Research ([link removed]) website in March.
------------------------------------------------------------
Virtual: American College Health Association offers third in five-part webinar series Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
The American College Health Association (ACHA) is offering a free, five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students ([link removed]) . This five-part webinar series will provide tools for campus personnel in all disciplines to use when working with students to help them navigate misinformation, disinformation, and the infodemic. Webinars include:
* January 10 – "Health Literacy 101" (available on-demand ([link removed]) )
* February 21 – "Digital Wellbeing and Mental Health: Helping Me Is Helping We" (available on-demand ([link removed]) )
* March 7 – "Debunking Fake News" (available on-demand ([link removed]) )
* April 18 – "Confronting Misinformation in Our Circles of Influence"
* May 9 – "Managing the Infodemic: Getting Started"
Each session airs 12:00–1:00 p.m. (ET). Up to 5 hours of credit are available for CNE, CME, and CHES, and 1.0 CE is available for counselors specifically for session 2.
Register for the free webinars ([link removed]) .
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp